The Immune Response to Viral InfectionsB.A. Askonas Virus diseases continue to represent serious health problems in most parts of the world. In spite of the fact that diseases such as polio myelitis and measles have been controlled in the industrialized countries by vaccination, vaccines now in use in tropical countries have proved not to be optimal. Further research is needed to develop new vaccines that will be effective in all countries. To do so we need to understand better the immune response to different viruses so that we may be able to maxi mize the protective response of new vaccines and minimize their potential immunopathologic effect. An exciting new discovery which is now being further developed is the possibility of being able to use some viruses (e.g. vaccinia, adenoviruses, etc.), as carriers for other antigens. This may open up the way for the production of vaccines that will be inexpensive and that will confer long lasting immunity after only one injection. This meeting has also served to review our present knowledge of virus diseases which are still of great importance such as hepatitis, dengue and influenza. |
Contents
The Contribution of Virus Infections to our Understanding | 1 |
TCells in Respiratory Syncytial Virus RSV Infection | 9 |
Nerves and Neuropeptides in the Regulation | 19 |
Copyright | |
23 other sections not shown
Other editions - View all
The Immune Response to Viral Infections B.A. Askonas,B. Moss,G. Torrigiani,S. Gorini Limited preview - 2012 |
The Immune Response to Viral Infections B.A. Askonas,B. Moss,G. Torrigiani,S. Gorini No preview available - 2012 |
The Immune Response to Viral Infections B.A. Askonas,B. Moss,G. Torrigiani,S. Gorini No preview available - 2012 |
Common terms and phrases
Acad acid activity adenovirus antibody production antibody response antigen antiviral assay capsid CD4+ CD8+ cell-mediated cellular Chanock chronic class I antigens Clin clinical clones cytotoxic T cells dengue detected DHF/DSS Dianzani diarrhea disease epitope expression gene genetic genome glycoprotein HBcAg HBsAg hepatitis B virus herpes simplex virus HLA class human papillomavirus immune response immunogenic Immunol immunological inactivated vaccine induced infected cells infected mice influenza vaccines influenza virus inoculation interferon Kapikian lesions live vaccine liver lung microglobulin molecule monoclonal antibodies mouse mucosal murine NK cell papillomavirus pathogenesis patients peptide poliovirus pre-S Proc protection protein receptors recognition recombinant region replication respiratory syncytial virus role rotavirus vaccine sequence sera serotype serum specific spleen strain studies T-cell target cells Tc cells tissue titres vector viral virion Virol virus infection viruses vitro vivo warts